13F HOLDINGS REPORT
Qiming U.S. Ventures Management, LLC
Quarter ended Q2 2024 · Filed August 13, 2024 · Accession 0001104659-24-088978
Total Value
$52.6M
Positions
6
Other Managers
0
Confidential Omitted
No
Holdings (6)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | JASPER THERAPEUTICS INC | JSPRW | 928,964 | $21.1M | 40.07% |
| 2 | KORRO BIO INC | KRRO | 368,085 | $12.5M | 23.69% |
| 3 | TOURMALINE BIO INC | 89157D105 | 741,691 | $9.5M | 18.13% |
| 4 | HILLEVAX INC | 43157M102 | 558,923 | $8.1M | 15.36% |
| 5 | VENTYX BIOSCIENCES INC | 92332V107 | 412,225 | $952,240 | 1.81% |
| 6 | KEZAR LIFE SCIENCES INC | KZR | 828,711 | $497,227 | 0.94% |